|
James
Abbruzzese, MD
Chairman, GI Oncology
M.D. Anderson Cancer Center
Markus
Büchler, MD
Chairman, Surgery
Heidelberg University, Germany
Ralph
Hruban, MD
Director, GI / Liver
Pathology
Johns Hopkins University
Eileen
O'Reilly, MD
Assistant Professor
Memorial Sloan-Kettering
Margaret
Tempero, MD
Chief, Medical Oncology
University of California - SF
Join us in Golden, Colorado for the
Pam Saunders Charity
Golf Tournament
June 28, 2010
How
to Use This Site
Professor Eileen O'Reilly
has co-authored “100 Questions and Answers About Pancreatic
Cancer” as published by Jones
& Bartlett. More information about this practical book,
including the means to buy it directly from the Publisher’s
website ($19.95), is found at the following link:
More Information
In Remembrance
Walter Leaman
Gary
Lorenzen
R. Gerald
Markle |
|
Do you have a neuroendocrine
tumor?  Would
you like to share your story with the media? Please contact webmaster@pancreatica.org.
Frequently
Asked Questions on Pancreatic Cancer
Answers to questions about pancreatic cancer such as What
are the Stages of Pancreatic Cancer?o learn more click
here...
Pancreatic
Cancer Clinical Trials Database
The world's largest listing of clinical
trials for pancreatic cancer
Examples include:
GV1001
and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy
in Pancreatic Cancer.
A Randomized Phase III Study of Weekly
ABI-007 Plus Gemcitabine Versus Gemcitabine Alone in Patients
With Metastatic Adenocarcinoma of the Pancreas.
Pancreatic
Cancer Medical Literature
Information from medical journals, clinical trials and news sources.
Orientation: new pancreatic cancer treatment findings
Examples include:
Prognostic
Impact of RT-PCR-Based Detection of Peritoneal Micrometastases
in Patients with Pancreatic Cancer Undergoing Curative Resection
ABO
Blood Group and the Risk of Pancreatic Cancer
Have fun.
Do good.
Click
here
|
|
RAISE AWARENESS
~ RAISE FUNDS
Select one of our
2009 Walks or Runs
Or Dedicate-A-Race and participate anywhere
Toll Free 1-877-ToFightCancer (877-863-4448)
Participate@ToFightCancer.com
|
For more information
and online registration click
here
|
Would you like to speak
with an experienced counselor about how pancreatic cancer is
affecting your life? |
|
Call 1-800-525-3777 for free counseling
on our Cancer Information and Counseling Line (CICL) from 8:30
to 4:30 (U.S. Mountain Time) Monday thru Friday.
This service is for all
who are affected by pancreatic cancer and is provided in collaboration
with the University of Colorado Cancer Center. |
|
|
|
- Neuroendocrine
Pancreatic Cancer Tumors
-
Information on islet-cell
and carcinoid cancers
- Neuroendocrine and Carcinoid Overview
Recent
Neuroendocrine Research Results
Carcinoid & Neuroendocrine
Select Abstracts
Neuroendocrine and Carcinoid
Clinical Trials
Neuroendocrine
and Carcinoid Links
Contribute
to Pancreatica Now & Fight Pancreatic Cancer !
CAPS
3 Study for those at High Risk for Pancreatic Cancer
- Would you
like to speak with a pancreatic cancer survivor?
Call 1-800-433-0464 for a free
service that will place you in contact with a fellow survivor,
or to volunteer to contact someone more recently diagnosed.
This peer-to-peer connection
service is offered in conjunction with the Bloch Cancer Hotline. |
|
Pancreatic
Cancer Survivor Stories
Read these stories
of long-term pancreatic cancer survivors by clicking here
Milo's
Corner for Survivor Research |
|
|
"Pancreatica.org is a site that MUST be searched by anyone
looking for a comprehensive listing of pancreatic cancer clinical
trials. It is well organized, readable and easy to navigate."
Howard Fuller, Medical
Librarian
Stanford University Medical Center |
|
Pancreatic
Cancer Registries
In this age of molecular
biology and armed with new understandings about the role that
genes play in pancreatic cancer, familial registries are increasingly
a powerful resource to help gain a better understanding of the
disease - and hence better detection or treatment possibilities.
There are about fifteen cancer
registries worldwide that are specific to cancer of the pancreas.
For more information please click here
Select
Abstracts for Pancreatic Cancer
 (most recent)
 For
access to all pancreatic cancer abstracts back to 2003, please
click here
Elevated Cancer Mortality in
the Relatives of Patients with Pancreatic Cancer.
Wang L, Brune KA, Visvanathan K, Laheru D, Herman J, Wolfgang
C, Schulick R, Cameron JL, Goggins M, Hruban RH, Klein AP.
Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2829-34. Johns
Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
[Link
to Abstract]
Induction Chemotherapy Followed
by Chemoradiation in Locally Advanced Pancreatic Cancer: An Effective
and Well-Tolerated Treatment.
Hudson E, Hurt C, Mort
D, Brewster AE, Iqbal N, Joseph G, Crosby TD, Mukherjee S.
Clin Oncol (R Coll Radiol). 2009 Nov 4. [Epub]. Clinical Oncology,
Velindre Hospital, Cardiff, UK.
[Link
to Abstract]
Phase III Randomized Comparison
of Gemcitabine Versus Gemcitabine plus Capecitabine in Patients
with Advanced Pancreatic Cancer.
Cunningham D, Chau I,
Stocken DD, Valle JW, Smith D, Steward W, Harper PG, Dunn J,
Tudur-Smith C, West J, Falk S, Crellin A, Adab F, Thompson J,
Leonard P, Ostrowski J, Eatock M, Scheithauer W, Herrmann R,
Neoptolemos JP.
J Clin Oncol. 2009 Nov 20;27(33):5513-8. Royal Marsden National
Health Service (NHS) Foundation Trust, London and Surrey, UK.
[Link
to Abstract]
A Randomised Phase II Study
of Modified FOLFIRI.3 Vs Modified FOLFOX as Second-Line Therapy
in Patients with Gemcitabine-Refractory Advanced Pancreatic Cancer.
Yoo C, Hwang JY, Kim
JE, Kim TW, Lee JS, Park DH, Lee SS, Seo DW, Lee SK, Kim MH,
Han DJ, Kim SC, Lee JL.
Br J Cancer. 2009 Nov 17;101(10):1658-63. Asan Medical Center,
University of Ulsan College of Medicine, Seoul, Korea.
[Link
to Abstract]
To all pancreatic cancer select
abstracts
- Select Links sm in Pancreatic Cancer
Follow survivor Chris Calaprice as he rides across America raising
pancreatic cancer awarness ... Please click here
-
- Genentech now offers its Single
Point of Contact (SPOC) program for aid in any reimbursement
issues related to Tarceva (in use for pancreatic cancer). Please click here
GlobeImmune offers a highly interesting Phase II trial with
its GI-4000 biologic (vaccine) against ras – an “oncogene”
that is mutated in most pancreatic cancers. Please click here
Roche Clinical Trial Protocol Registry. Please click here
The Pancreatic Duct. Please click here
-
- TNFerade approved for orphan
treatment status for pancreatic cancer. Please click here
-
- Recent News Articles
on Pancreatic Cancer
Pancreatic Cancer
Alliance news summaries click here
Google Newswire click here
- Advocacy
for Pancreatic Cancer
Pancreatica.org
continues to support legislative and other effort aimed at increasing
the funding support for pancreatic cancer treatment and research.
more...
- General
Information
- Pancreatic cancer is the most
aggressive of the cancers
- Pancreatic cancer causes more
than 1% of all death in the U.S.
- Pancreatic cancer is the least
funded of the major cancers
Cancer is the second most common
cause of death in the developed world, behind cardiovascular
disease. Pancreatic cancer is the fourth most common cause of
cancer mortality (behind lung cancer, colorectal cancer and breast
cancer).
250 people in North America and
Europe will die today from pancreatic cancer. (90,000 deaths
per year).
The U.S. National Cancer Institute
funds pancreatic cancer research at shockingly low levels (year
2005-07 figures). Pancreatic cancer research receives (per mortality):
 15%
of the funding of breast cancer (but causes 82% of the mortality)
17% of the funding of prostate
cancer (but causes more mortality)
41% of the funding of colorectal
cancer (but causes 63% of the mortality)
Supporters of Our Effort Against Pancreatic
Cancer
Compassionate generosity from the philanthropic and business
world
How
Are We Doing?
Please give us feedback |